# Cardax Pharma, Inc. — Form D

Cardax Pharma, Inc. of HONOLULU, HI, a company, filed a Form D exempt-offering notice with the SEC on 2013-06-17. The offering totals $10.0M, of which $781K was reported sold. Industry: Pharmaceuticals.

## Offering

- Filed: 2013-06-17
- Form: D
- Accession: 0001579166-13-000001
- Industry: Pharmaceuticals
- Exemptions: 06
- Total offering: $10.0M
- Amount sold: $781K
- Remaining: $9.2M
- Minimum investment: $250K
- Investors: 3
- Date of first sale: 2013-05-31
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-198097

## Issuer

- Name: Cardax Pharma, Inc.
- CIK: 0001579166
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2013
- Address: 2800 WOODLAWN DRIVE, HONOLULU, HI, 96822
- Phone: 808-457-1399

## Officers, directors & promoters (3)

| Name | Role | Location |
| --- | --- | --- |
| David G Watumull | Executive Officer | Honolulu, HI |
| Nicholas G Mitsakos | Director | Honolulu, HI |
| Frank C Herringer | Director | Thousand Oaks, CA |

## Other filings by this issuer (1)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2014-01-17](https://search.stillhousedata.com/formd/0001579166-14-000001) | D | $5.0M | $2.1M |

## More

- [CIK 1579166 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1579166&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001579166-13-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.